Internet Portal Set to Assist Drug Discovery Studies

A sophisticated new Internet portal designed to promote and assist drug discovery studies will give researchers in medicinal chemistry, pharmacology, drug metabolism, and pharmacokinetics access to a range of up-to-date databases containing a vast amount of information.

The new web portal is the brainchild of the French company Aureus Sciences (Paris, France), formerly called Aureus Pharma. The portal will provide easy access to its content through a series of sophisticated search and index applications.

Experts at Aureus Sciences continuously monitor and organize the most relevant information from the scientific literature, including experimental in vitro and in vivo protocols. This detailed knowledge forms the "AurSCOPE” database line, focusing on the human body's main therapeutic targets: GPCRs (G protein-coupled receptors), kinases, ion channels, proteases, and nuclear receptors. Additional "AurSCOPE” databases relate to safety, toxicology, and pharmacokinetics. Applications include "AurQUEST,” the web-based query tool, "DDI Predict” for drug-drug interactions, and "AurPROFILER”, the compound profiling visualization tool.

"The new Aureus-Sciences application portal is a major achievement for our company,” said Dr. Jason Theodosiou, president and CEO of Aureus Sciences. "For the first time we are offering a unique single-point access to all of our tools, applications, notes, scientific communications, and technical documentation. This will make it substantially easier for our prospective customers to make use of our know-how, provide more comprehensive interaction, and help them accelerate their research projects with data they can trust.”

Related Links:
Aureus Sciences